Int’l Biotechnology consults investors after fund group resigns
SV Health, manager of the £300m International Biotechnology Trust, serves 12-month notice, saying it wants to focus on its healthcare venture business.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Int’l Biotechnology up for grabs after SV Health serves notice
Board of £300m International Biotechnology Trust consults big shareholders after fund manager SV Health serves 12-month notice, saying it wants to focus on its healthcare venture business.
BH Macro raises £315m to lift assets by quarter
Share issue of £1.3bn Brevan Howard hedge fund was mainly backed by institutional and professional investors, but private investors subscribed for £66m of sterling shares.
Hedge fund BH Macro raises £315m on strong investor demand
Brevan Howard hedge fund lifts assets by a quarter after institutional and professional investors take advantage of keenly-priced share issue from the all-weather performer.
3i Infrastructure takes in £100m from ‘stale’ share issue
Analysts' concerns over the price of this week's fund raise have not deterred investors, although the company has perhaps had to settle for less than it wanted.
3i Infrastructure scales back ‘stale’ share issue to £100m
(Update) Concerns over price of this week’s fundraise have not deterred investors, although the company has perhaps had to settle for less than it wanted. It may bode well for the flotation of rival infrastructure fund AT85.
Syncona ploughs £93m into life sciences amid tight biotech financing
Life sciences fund has plenty of cash to pursue its ambition to become a £5bn biotech platform, even if investors are giving its shares the cold shoulder at the moment.
AEW star Alex Short joins Alvarium-owned LXI
Former manager of top-performing AEW UK Reit joins LXI Reit Advisors as chief investment officer as its long-leased property fund reports good rent rises but sees its shares falter on a corporate connection to embattled Home Reit.
ICG Enterprise brings in fee cap to benefit shareholders
The private equity fund of funds applies a management fee cap as it looks to attract investors and re-rate shares that trail 37% below the value of the trust’s assets.
Augmentum buys first cyber insurance platform, adds to Zopa
The European private equity investment trust buys its first cyber insurance platform Baobab and adds to fast-growing digital bank, Zopa.
Chrysalis falls after buying third of Jupiter’s Starling stake
Shares in Jupiter’s under-pressure growth capital fund drop 6% on deal to buy £20m of unquoted Starling bank from Jupiter UK Mid Cap fund, run by co-manager Richard Watts. Analysts say the transaction increases Chrysalis' risks.
Jupiter sells Starling, bans unlisted stocks from open-ended funds
Fund group sells stake in unlisted digital bank Starling and rules its open-ended funds will no longer invest in private companies. Jupiter's closed-end fund Chrysalis is one of the buyers though.
